Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
Amylyx Pharmaceuticals (Nasdaq: AMLX) has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management will deliver a corporate presentation on Wednesday, April 9, 2025, at 8:00 a.m. ET.
Interested parties can access a live webcast of the presentation through the 'Events and Presentations' section of the company's investor relations website at investors.amylyx.com. The presentation recording will remain available for replay on the website for 90 days after the event.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha annunciato la sua prossima partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute. La direzione dell'azienda presenterà un intervento aziendale mercoledì 9 aprile 2025, alle 8:00 ET.
Le parti interessate possono accedere a una trasmissione in diretta della presentazione attraverso la sezione 'Eventi e Presentazioni' del sito web delle relazioni con gli investitori dell'azienda all'indirizzo investors.amylyx.com. La registrazione della presentazione rimarrà disponibile per la visione in differita sul sito per 90 giorni dopo l'evento.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Needham sobre Salud. La dirección de la empresa realizará una presentación corporativa el miércoles 9 de abril de 2025, a las 8:00 a.m. ET.
Las partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la sección 'Eventos y Presentaciones' del sitio web de relaciones con inversores de la empresa en investors.amylyx.com. La grabación de la presentación permanecerá disponible para su reproducción en el sitio durante 90 días después del evento.
아밀릭스 제약(Amylyx Pharmaceuticals) (Nasdaq: AMLX)은 제24회 니드햄 가상 의료 회의에 참여할 예정이라고 발표했습니다. 회사 경영진은 2025년 4월 9일 수요일 오전 8시(동부 표준시)에 기업 발표를 진행할 것입니다.
관심 있는 분들은 회사의 투자자 관계 웹사이트인 investors.amylyx.com의 '이벤트 및 발표' 섹션을 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다. 발표 녹화는 행사 후 90일 동안 웹사이트에서 재생할 수 있습니다.
Amylyx Pharmaceuticals (Nasdaq: AMLX) a annoncé sa prochaine participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé. La direction de l'entreprise fera une présentation d'entreprise le mercredi 9 avril 2025, à 8h00 ET.
Les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section 'Événements et Présentations' du site web des relations investisseurs de l'entreprise à l'adresse investors.amylyx.com. L'enregistrement de la présentation restera disponible en replay sur le site pendant 90 jours après l'événement.
Amylyx Pharmaceuticals (Nasdaq: AMLX) hat seine bevorstehende Teilnahme an der 24. jährlichen virtuellen Gesundheitskonferenz von Needham angekündigt. Das Management des Unternehmens wird am Mittwoch, den 9. April 2025, um 8:00 Uhr ET eine Unternehmenspräsentation halten.
Interessierte Parteien können über den Bereich 'Veranstaltungen und Präsentationen' auf der Investor-Relations-Website des Unternehmens unter investors.amylyx.com auf einen Live-Stream der Präsentation zugreifen. Die Aufzeichnung der Präsentation wird für 90 Tage nach der Veranstaltung auf der Website verfügbar sein.
- None.
- None.
A live webcast of the presentation can be accessed under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/events-presentations, and will be available for replay for 90 days following the event.
About Amylyx Pharmaceuticals
At Amylyx, our mission is to usher in a new era of treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are currently focused on three investigational therapies across several neurodegenerative and endocrine diseases in which we believe they can make the greatest impact. For more information, visit amylyx.com and follow us on LinkedIn and X. For investors, please visit investors.amylyx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402678227/en/
Media
Amylyx Media Team
+1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors
Lindsey Allen
Amylyx Pharmaceuticals, Inc.
+1 (857) 320-6244
Investors@amylyx.com
Source: Amylyx Pharmaceuticals, Inc.
FAQ
When is Amylyx Pharmaceuticals (AMLX) presenting at the Needham Healthcare Conference 2025?
How can investors watch the AMLX presentation at the Needham Conference?
How long will the AMLX Needham Conference presentation replay be available?
Which healthcare conference is AMLX participating in April 2025?
